News | December 17, 2024
Merck to acquire HUB Organoids to advance cell culture portfolio
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The emergence of new infections in India is a growing concern
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Subscribe To Our Newsletter & Stay Updated
